Search

Your search keyword '"Noushmehr, Houtan"' showing total 609 results

Search Constraints

Start Over You searched for: Author "Noushmehr, Houtan" Remove constraint Author: "Noushmehr, Houtan"
609 results on '"Noushmehr, Houtan"'

Search Results

1. The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?

2. Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas

3. Glioma progression is shaped by genetic evolution and microenvironment interactions

4. Detection of diagnostic and prognostic methylation-based signatures in liquid biopsy specimens from patients with meningiomas

5. Development of ‘Core Outcome Sets’ for Meningioma in Clinical Studies (The COSMIC Project): protocol for two systematic literature reviews, eDelphi surveys and online consensus meetings

6. Advances in Central Nervous System Tumor Classification

7. Predicting master transcription factors from pan-cancer expression data

8. A global metagenomic map of urban microbiomes and antimicrobial resistance.

9. Longitudinal molecular trajectories of diffuse glioma in adults

10. A Study of High-Grade Serous Ovarian Cancer Origins Implicates the SOX18 Transcription Factor in Tumor Development

11. The Immune Landscape of Cancer

12. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management.

13. Super-Enhancer-Associated LncRNA UCA1 Interacts Directly with AMOT to Activate YAP Target Genes in Epithelial Ovarian Cancer

14. Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women

15. A transcriptome-wide association study of high-grade serous epithelial ovarian cancer identifies new susceptibility genes and splice variants

16. Functional analysis and fine mapping of the 9p22.2 ovarian cancer susceptibility locus

17. Imaging and diagnostic advances for intracranial meningiomas.

18. Molecular and translational advances in meningiomas

20. Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium

21. The Immune Landscape of Cancer

22. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer

23. Optimizing exosomal RNA isolation for RNA-Seq analyses of archival sera specimens.

24. Impact of genomic background and developmental state on signaling pathways and response to therapy in glioblastoma patient-derived cells

25. Table S1 from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

26. Supp Figures from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

27. Supplemental Figures Legends from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

28. Data from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

29. Supplementary Appendix from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

30. Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas

31. Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1

32. The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

33. The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen

34. Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology

36. Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci

37. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

38. MODL-14. IMAGING, HISTOLOGICAL AND MOLECULAR CHARACTERIZATION AND COMPARISON OF POST-ABLATION RECURRENT TUMOR WITH THE PRIMARY TUMOR IN A PRECLINICAL GLIOBLASTOMA MODEL

40. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

41. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

42. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

43. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

44. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

45. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types

46. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

47. Systematic Analysis of Splice-Site-Creating Mutations in Cancer

48. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

49. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

50. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types

Catalog

Books, media, physical & digital resources